2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Ross, Douglas S., Burch, Henry B., Cooper, David S., Greenlee, M. Carol, Laurberg, Peter, Maia, Ana Luiza, Rivkees, Scott A., Samuels, Mary +3 more·2016·Thyroid®

Cited by (1,000)

Items 801–900 of 1,000

  1. Efficacy and safety of tripterygium glycosides in the treatment of hyperthyroidism
    Chunyan Xie, Chaozhu He, Jun Yi Gao · 2020 · Medicine
  2. Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta‐Analysis
    Dan Shan, Li Zou, Xi-Jiao Liu, Yitong Cai, Ruihong Dong, Yayi Hu · 2020 · BioMed Research International
  3. The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease
    Yulin Zhou, Mengxi Zhou, Yicheng Qi, Weiqing Wang, Xinxin Chen, Shu Wang · 2021 · Therapeutic Advances in Endocrinology and Metabolism
  4. Serum TSH level as predictor of Graves’ disease recurrence following antithyroid drug withdrawal: A systematic review
    Imam Subekti, Gracia Jovita Kartiko, Zahra Farhanni Suhardi, Muhadi Muhadi, Wismandari Wisnu · 2021 · PLoS ONE
  5. Challenges in the Management of Thyrotoxicosis Associated with Atrial Fibrillation and Heart Failure: Two Case Reports
    Abid M. Sadiq, Nyasatu Godfrey Chamba · 2021 · Clinical Medicine Insights Case Reports
  6. Thyroid storm in the second stage of labour: a case report
    Yudianto Budi Saroyo, Achmad Kemal Harzif, Beryliana Maya Anisa · 2021 · BMJ Case Reports
  7. Clinical efficacy of fixed-dose radioactive iodine for the treatment of hyperthyroidism at a single centre: our experience
    Dilip Nair, Robert Munashe Maweni, Christoforos Constantinou, Shivanthi Kandiah, Sidhartha Nagala, Theingi Aung · 2021 · Irish Journal of Medical Science (1971 -)
  8. FOXP3 and IL-10 overexpression: A novel diagnostic biomarker in Iraqi patients having hyperthyroidism treated with radioactive iodine
    Zena Abdullah Khalaf, Hameed Majeed Jasim, Ali Abdul Al Hussain Mahdi · 2021 · Gene Reports
  9. The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study
    Cheng‐Chieh Chang, Szu-Ying Wu, Yun‐Ru Lai · 2022 · Evidence-based Complementary and Alternative Medicine
  10. Role of Thyroid RFA in the Treatment of Autonomously Functioning Thyroid Nodules
    Alan Alper Sag, Hadiza Shu’aib Kazaure, Carly E. Kelley · 2022 · Techniques in vascular and interventional radiology
  11. Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
    Yoon Young Cho, Bongseong Kim, Dong Wook Shin et al. · 2022 · Endocrinology and Metabolism
  12. Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study
    Raweewan Lertwattanarak, Tada Kunavisarut, Sutin Sriussadaporn · 2022 · International Journal of Endocrinology
  13. Impact of Definitive Surgery for Graves' Disease on Adolescent Disease-Specific Quality of Life and Psychosocial Functioning
    Stephen Halada, Julia A. Baran, Amber R. Isaza, Tasleema Patel, Lindsay Sisko, Ken Kazahaya, N. Scott Adzick, William Rocamora Katowitz, Leanne Magee, Andrew J. Bauer · 2022 · Thyroid
  14. Short-Term Complications After Total Thyroidectomy in Children
    Audra J. Reiter, Andrew Hu, Gwyneth A. Sullivan · 2022 · Journal of Surgical Research
  15. Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
    Yuyang Ze, Fei Shao, Xuefeng Feng, Shanmei Shen, Yan Bi, Dalong Zhu, Xiaowen Zhang · 2022 · BMC Endocrine Disorders
  16. Pediatric hyperthyroidism and thyroid eye disease management
    Joy Li, Juliana Austin, Raymond S. Douglas, Sudha Nallasamy · 2023 · Journal of American Association for Pediatric Ophthalmology and Strabismus
  17. Identification and Management of Thyroid Dysfunction Using At-Home Sample Collection and Telehealth Services: Retrospective Analysis of Real-World Data
    Kathleen M. Gavin, Daniel S. Kreitzberg, Yvette Gaudreau, Marisa L. Cruz, Timothy A. Bauer · 2023 · Journal of Medical Internet Research
  18. Associations between Lipid Profiles and Graves’ Orbitopathy can Be HLA-Dependent
    Magdalena Stasiak, Katarzyna Zawadzka-Starczewska, Bogusław Tymoniuk · 2023 · Genes
  19. Gut microbiome in the Graves’ disease: Comparison before and after anti-thyroid drug treatment
    Chaiho Jeong, Han-Sang Baek, Jaewoong Bae, Nakwon Hwang, Jeonghoon Ha, Young‐Seok Cho, Dong‐Jun Lim · 2024 · PLoS ONE
  20. A methimazole resistant patient with Graves’ disease (GD): A case report of mid-term management with herbal decoctions mainly composed of Anemarrhena Bunge
    Jiman Kim, Tae‐Hun Kim · 2018 · Complementary Therapies in Medicine
  21. Graves’ disease in children in the two decades following implementation of an iodine prophylaxis programme
    Ada Borowiec, Dominika Labochka, Monika Milczarek, Monika Kopiec-Burdecka, Dorota Artemniak-Wojtowicz, Beata Pyrżak, Anna Kucharská · 2018 · Central European Journal of Immunology
  22. Design of a predictive score to assess the risk of developing hypocalcemia after total thyroidectomy. A retrospective study
    Anastasios Papanastasiou, Konstantinos G. Sapalidis, Stylianos Mantalobas et al. · 2019 · International Journal of General Medicine
  23. Long-Term Antithyroid Drug Treatment of Patients With Graves’ Disease
    David S. Cooper · 2019 · Clinical Thyroidology
  24. Hyperthyroid heart disease in pregnancy: Retrospective analysis of a case series and review of the literature
    Dan Shan, Yi Bai, Qiu-He Chen, Yuxia Wu, Qian Chen, Yayi Hu · 2019 · World Journal of Clinical Cases
  25. Direct bilirubin level is an independent risk factor for atrial fibrillation in thyrotoxic patients receiving radioactive iodine therapy
    Danyang Sun, Wei Li, Wei Zheng · 2019 · Nuclear Medicine Communications
  26. Marked elevation of creatine phosphokinase alone caused by sintilimab - beware of hypothyroid myopathy
    Jun Ni, Li Zhang, Xiaotong Zhang · 2020 · European Journal of Cancer
  27. Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment
    Danilo Villagelin, Roberto Boettier dos Santos, João Hamilton Romaldini · 2020 · Intern J Endocrinol Metab
  28. Subclinical male hypogonadism
    Giovanni Corona, Giulia Rastrelli, Mauro Dicuio, Sergio Concetti, Marianna Minnetti, Rosario Pivonello, Andrea Maria Isidori, Alessandra Sforza, Mario Maggi · 2020 · Minerva Endocrinology
  29. SARS‐CoV‐2 infection and paediatric endocrine disorders: Risks and management considerations
    Ryan S. Miller, Ambika P. Ashraf, Evgenia Gourgari, Anshu Gupta, Manmohan K. Kamboj, Brenda Kohn, Amit Lahoti, Daniel Mak, Shilpa Mehta, Deborah M. Mitchell et al. · 2021 · Endocrinology Diabetes & Metabolism
  30. Thoughts on the Japanese and American Perspectives on Thyroid Storm
    Ulla Feldt‐Rasmussen, Charles H. Emerson, Douglas S. Ross · 2019 · Thyroid
  31. CACA guidelines for holistic integrative management of thyroid cancer
    Minghua Ge, Ming Gao, Ruochuan Cheng, Xiaohong Chen, Haixia Guan, Yansong Lin, Shaoyan Liu, Yu Wang, Chuanming Zheng, Xiangqian Zheng · 2022 · Holistic Integrative Oncology
  32. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction
    João Sérgio Neves, Ana Rita Leite, Glória Conceição, Alexandre Gonçalves, Marta Borges‐Canha, Catarina Vale, Madalena von Hafe, Diana Martins, Daniela Miranda‐Silva, Sara Leite et al. · 2023 · Thyroid
  33. Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study
    Yuichiro Matsuo, Atsushi Miyawaki, Hideaki Watanabe, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga · 2024 · The Journal of Clinical Endocrinology & Metabolism
  34. Is there any association between fluoride exposure and thyroid function modulation? A systematic review
    Maria Karolina Martins Ferreira, Priscila Cunha Nascimento, Leonardo Oliveira Bittencourt · 2024 · PLoS ONE
  35. Eltroxin and Hesperidin mitigate testicular and renal damage in hypothyroid rats: amelioration of oxidative stress through PPARγ and Nrf2/HO-1 signaling pathway
    Hadeel M. Osama, Sally Mostafa Khadrawy, El‐Shaymaa El‐Nahass, Sarah I. Othman, Hanaa Mahmoud Mohamed · 2024 · Laboratory Animal Research
  36. Global research landscape and emerging trends in Graves’ disease: A bibliometric analysis
    Yan Yang, Peijin Li, Chunjian Zhou, Feng Liu, Tao Liu, Qian Wang, Zhiguo Ding · 2024 · Medicine
  37. Hyperthyroidism, hypothyroidism, thyroid stimulating hormone, and dementia risk: results from the NHANES 2011–2012 and Mendelian randomization analysis
    Xixi Sheng, Jixiang Gao, Kunfei Chen, Xuzhen Zhu, Yu Wang · 2024 · Frontiers in Aging Neuroscience
  38. Ultrasound-guided percutaneous microwave ablation of primary hyperthyroidism: security and efficacy analysis
    Jing-E Zhu, Chun-Jun Sheng, Huili Zhang, Jiaxin Li, Xiao‐Wan Bo, Jia-Jing Yin, Peng Yang, Song-Yuan Yu, Liping Sun · 2024 · International Journal of Hyperthermia
  39. Subclinical/overt hypothyroidism may be associated with diminished ovarian reserve in infertile women independent of thyroid autoimmunity
    Hongzhan Zhang, Han Qiu, Zhiqiang Liu, Yulian Wu, Wei Liu, Chunyu Huang · 2024 · Frontiers in Endocrinology
  40. A Predictive Model for Graves’ Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study
    Omar M. El Kawkgi, David Toro-Tobón, Freddy J.K. Toloza, Sebastián Vallejo, Cristian Soto Jacome, Ivan N. Ayala, Bryan Alexis Vallejo, Camila Wenczenovicz, Olivia Tzeng, Horace Jack Spencer et al. · 2024 · Endocrine Practice
  41. Thyroid‐Targeted Nano‐Bombs Empower HIFU for Graves' Disease
    Binhao Wang, Zhuobing Yin, Xiangyue You · 2025 · Advanced Science
  42. Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review
    Jacopo Manso, Ilaria Muller, Caterina Mian · 2025 · European Thyroid Journal
  43. Therapeutic plasmapheresis in the management of thyrotoxicosis: a-retrospective study with emphasis on critically ill patients
    Ümmü Mutlu, Fatih Bektaş, Senem Dadin, Hülya Hacışahinoğulları, Yalın İşcan, Gülşah Yenidünya Yalın, Nurdan Gül, Özlem Soyluk Selçukbiricik, Sevgi Kalayoğlu Beşışık, Ayşe Kubat Üzüm · 2025 · Endocrine
  44. Risk factors for hypocalcemia after total thyroidectomy: a narrative review
    Bohan Cao, Guangzhe Wu · 2025 · PeerJ
  45. Quality, Reliability and Accuracy of Hyperthyroidism‐Related Content on Social Media Platform TikTok
    Aayush Shah, Raika Bourmand, Freddy Albaladejo, Karthik Jarugula, Sofia Eva Olsson, Zainab Farzal, Viraj Shah · 2025 · Endocrinology Diabetes & Metabolism
  46. Approach to the patient with thyroid storm
    Peter Andreas Kopp, Ilaria Giordani, Ulla Feldt‐Rasmussen, Aurelie Forget-Renaud · 2026 · The Journal of Clinical Endocrinology & Metabolism
  47. Radioiodine treatment of pediatric Graves disease: a multicenter review
    Andrew T. Trout, Hedieh K. Khalatbari, Gbenga Shogbesan · 2022 · Pediatric Radiology
  48. Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
    Valentina Capelli, Carmen Grijota-Martínez, Nathalia Romanelli Vicente Dragano, Eva Rial‐Pensado, Johan Fernø, Rubén Nogueiras, Jens Mittag, Carlos Diéguez, Miguel López · 2021 · Nutrients
  49. Accumulation of Experience and Newly Developed Devices Can Improve the Safety and Voice Outcome of Total Thyroidectomy for Graves’ Disease
    Cheng‐Hsun Chuang, Tzu‐Yen Huang, Tzer‐Zen Hwang, Che‐Wei Wu, I‐Cheng Lu, Pi‐Ying Chang, Yi‐Chu Lin, Ling‐Feng Wang, Chih-Chun Wang, Ching‐Feng Lien et al. · 2022 · Journal of Clinical Medicine
  50. Risk of Permanent Hypoparathyroidism Requiring Calcitriol Therapy in a Population-Based Cohort of Adults Older Than 65 Undergoing Total Thyroidectomy for Graves' Disease
    Carolyn Dacey Seib, Tong Meng, Robin M. Cisco, Dana T. Lin, Elizabeth A. McAninch, Julie Chen, Manjula Kurella Tamura, Amber W. Trickey, Electron Kebebew · 2022 · Thyroid
  51. DRESS/DiHS syndrome induced by Propylthiouracil: a case report
    Qiong Shen, Qingyao Wang, Huanhuan Zang · 2023 · BMC Endocrine Disorders
  52. Effectiveness and potential mechanism of Jiawei-Xiaoyao-San for hyperthyroidism: a systematic review
    Wenxin Ma, Xiaowen Zhang, Ruotong Zhao et al. · 2023 · Frontiers in Endocrinology
  53. Integrated microbiome and metabolome analysis reveals a distinct microbial and metabolic signature in Graves' disease and hypothyroidism
    Wen Jiang, Ganghua Lu, Tingting Qiao, Xiaqing Yu, Qiong Luo, Junyu Tong, Suyun Fan, Li Chai, Dingwei Gao, Ru Wang et al. · 2023 · Heliyon
  54. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta‐analysis
    Xiaodong Liu, Carlos King Ho Wong, Tingting Wu, Wing‐Lok Chan, Yu Cho Woo, Cindy Lo Kuen Lam, Brian Hung‐Hin Lang · 2024 · World Journal of Surgery
  55. Cancer Risk in Graves Disease with Radioactive131I Treatment: A Nationwide Cohort Study
    Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi et al. · 2024 · Journal of Nuclear Medicine
  56. Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management
    Jin Wang, Ke Wan, Xin Chang, Ruifeng Mao · 2024 · World Journal of Diabetes
  57. Efficacy and safety of ultrasound-guided thermal ablation of graves’ disease: a retrospective cohort study
    Guangzhen Cai, Beilin Luo, Maolin Wang, Jiqin Su, Luping Lin, Guibin Li, Xiangru Chen, Zhishu Huang, Peiyi Lin, Shengwei Liu et al. · 2024 · Thyroid Research
  58. Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024
    Young Joo Park, Eun Kyung Lee, Young Shin Song, Su Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung‐Kuk Baek, So Won Oh, Min Kyoung Lee et al. · 2024 · International Journal of Thyroidology
  59. Orbital decompression following treatment with teprotumumab for thyroid eye disease
    Nicole J. Topilow, Rafaella Cleto Penteado, Michelle A. J. Ting · 2024 · Canadian Journal of Ophthalmology
  60. Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach
    Qingfeng He, Min Li, Peiying Ji, Aole Zheng, Li Yao, Xiao Zhu, Jae‐Gook Shin, Volker Martin Lauschke, Bing Han, Xiaoqiang Xiang · 2024 · Toxicology and Applied Pharmacology
  61. From routine to rescue: Thyroidectomy for life‐threatening thyrotoxicosis
    Zhixing Song, Ramsha Akhund, Christopher Wu · 2024 · World Journal of Surgery
  62. A narrative review of long-term inorganic iodine monotherapy for Graves’ disease with a historical relationship between iodine and thyroid
    Natsuko Watanabe · 2024 · Endocrine Journal
  63. Thyroid storm in a patient with unknown hyperthyroidism during nonthyroidal surgery—a case report and literature review
    Peiqi Shao, Jing Li, Danxu Ma · 2024 · BMC Anesthesiology
  64. Liver Dysfunction in a Patient with Graves’ Disease
    Filipa Campos, Angelica Sharma, Bijal Patel, Deborah Papadopoulou, Alexander N. Comninos, Ali Abbara · 2024 · Journal of Clinical Medicine
  65. Incidental Thyroid Cancer in Patients With Graves’ Disease: Not as Rare as We Previously Believed
    Shaidy Moronta, Lauren Slattery, Rongzhi Wang · 2025 · Journal of Surgical Research
  66. Molecular radiotheragnostics in thyroid disease
    Nitasha Singh, Valerie J. Lewington · 2017 · Clinical Medicine
  67. Choosing Wisely in autoimmunologia: le 5 Proposte del Gruppo di Studio in Autoimmunologia della SIPMeL
    Nicola Bizzaro, Marcello Bagnasco, Renato Tozzoli, Ignazio Brusca, Luigi Cinquanta, Marilina Tampoia, Gaia Deleonardi, Antonio Antico, Giampaola Pesce, Maria Grazia Alessio et al. · 2018 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  68. Thyreotoxische Krise und Myxödemkoma
    Malte Milkau, Friedhelm Sayk · 2018 · DMW - Deutsche Medizinische Wochenschrift
  69. Weathering the Crisis: A Case of Thyroid Crisis with Propranolol-Induced Circulatory Collapse Successfully Treated with Therapeutic Plasma Exchange
    Jean Mun Cheah, Danish Ng, Ming Yoong Low · 2019 · Journal of the ASEAN Federation of Endocrine Societies
  70. Serum Fibroblast Growth Factor 21 Levels in Patients with Hyperthyroidism and its Association with Body Fat Percentage
    A. R. Bande, P. Kalra, M. Dharmalingam, Chitra Selvan, K. Suryanarayana · 2019 · Indian journal of endocrinology and metabolism
  71. Biochemical pattern of thyroid function test and clinical impression of thyroid disorder in a rural tertiary health institution in Nigeria
    AhmedKayode Jimoh, MuritalaSegun Ghazal, Adewoyin Babajide Adeleke, Adebayo Augustine Adeniyi, Idowu Oluwaseyi Adebara, FataiOlakunle Babalola, Gbadebo Oladimeji Ajani, Matthew Segun Agboola, Olusegun Adesola Busari · 2020 · Annals of African Medicine
  72. Effects of Thyroid Function on Phosphodiester Concentrations in Skeletal Muscle and Liver: An In Vivo NMRS Study
    Hannes Beiglböck, Peter S. Wolf, Lorenz Pfleger, Burak Caliskan, Paul Fellinger, Georg Zettinig, Christian Heinz Anderwald, Lukas Kenner, Siegfried Trattnig, Alexandra Kautzky‐Willer et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
  73. Anaesthesia for ophthalmic procedures in patients with thyroid eye disease
    Alfred WY Chua, Chandra Mohan Kumar, Matthew J Chua, Brian P Harrisberg · 2020 · Anaesthesia and Intensive Care
  74. Review of European Thyroid Association Guideline (2018) for the Manage-ment of Graves’ Hyperthyroidism
    Valentin V. Fadeev · 2020 · Clinical and experimental thyroidology
  75. Low TSH Is Associated With Frailty in an Older Veteran Population Independent of Other Thyroid Function Tests
    Nalini S Bhalla, Karyne Lima Vinales, Ming Li, Richa Bhattarai, Janet Fawcett, Sherman Mitchell Harman · 2021 · Gerontology and Geriatric Medicine
  76. Role of dietary factors in thyroid disorders: Current evidences and way forwards
    MDAbu Bashar, Nazia Begam · 2020 · Thyroid Research and Practice
  77. Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a Saudi population
    Awad Saad Alshahrani, Ghulam Mustafa Shah Syed, Altaf Husain Khan · 2021 · Annals of Saudi Medicine
  78. US-guided percutaneous microwave ablation for hyperthyroidism and immediate treatment response evaluation with contrast-enhanced ultrasound
    Jing-E Zhu, Huili Zhang, Song-Yuan Yu, Hui‐Xiong Xu · 2021 · Clinical Hemorheology and Microcirculation
  79. How to use thionamide anti-thyroid drug in the young– what’s new?
    Tim D Cheetham · 2021 · Thyroid Research
  80. Management of Feline Hyperthyroidism and the Need to Prevent Oxidative Stress: What Can We Learn from Human Research?
    Alessia Candellone, Vittorio Saettone, P. Badino · 2021 · Antioxidants
  81. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease
    Marius Nicolae Stan, Alicia Algeciras‐Schimnich, Vishakantha Murthy, Prabin Bikram Thapa, Naohiro Araki · 2021 · Thyroid
  82. Mistaken Identity: The Role of Autoantibodies in Endocrine Disease
    Heather A. Nelson, Hemant R Joshi, Joely A. Straseski · 2021 · The Journal of Applied Laboratory Medicine
  83. Immune-related Thyroid Dysfunction (irTD) in Non-small Cell Lung Cancer (NSCLC) Correlates With Response and Survival
    Mario Giovanni Chilelli, Carlo Signorelli, Julio Rodrigo Giròn Berrìos, Angelo Onorato, Fabrizio Nelli, Agnese Fabbri, Francesca Primi, Eleonora Marrucci, Antonella Virtuoso, Marta Schirripa et al. · 2022 · Cancer Diagnosis & Prognosis
  84. Differences in immunophenotypes between myasthenia gravis patients with and without thyroid antibodies
    Qing Zhang, Zhuajin Bi, Mengge Yang, Mengcui Gui, Bitao Bu · 2022 · Muscle & Nerve
  85. Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves’ Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method
    Verena Theiler‐Schwetz, Thomas Benninger, Christian Trummer, Stefan Pilz, Markus Reichhartinger · 2022 · Frontiers in Endocrinology
  86. Non-diabetic ketoacidosis secondary to primary hyperthyroidism
    A. Al-Mashdali, M. Gul, Waseem Umer, Abeer A Omar, Akhnuwkh Jones · 2022 · Medicine
  87. Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade
    Alessandro Brancatella, Laura Pierotti, Nicola Viola, Isabella Lupi, Lucia Montanelli, Chiara Cremolini, Paolo Piaggi, Antonio Chella, Andrea Antonuzzo, Daniele Sgrò et al. · 2022 · European Thyroid Journal
  88. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment
    Navid Saadat, Fereidoun Azizi, Hengameh Abdi, Atieh Amouzegar · 2022 · Journal of Endocrinological Investigation
  89. Differential Diagnosis of Thyrotoxicosis by Machine Learning Models with Laboratory Findings
    Jinyoung Kim, Han-Sang Baek, Jeonghoon Ha, Mee Kyoung Kim, Hyuk‐Sang Kwon, Ki‐Ho Song, Dong‐Jun Lim, Ki‐Hyun Baek · 2022 · Diagnostics
  90. Correlation of Hypothyroidism With Disease Activity Score-28 in Patients of Rheumatoid Arthritis
    Amer Zohaib, Aflak Rasheed, Tafazzul-E-Haque Mahmud · 2022 · Cureus
  91. 99mTc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis
    Ray Wang, Nathan Better, Dinesh A. Sivaratnam · 2022 · Clinical Nuclear Medicine
  92. Time to Symptom Resolution After Total Thyroidectomy for Graves’ Disease
    Andrea Gillis, Ruth N. Obiarinze, M. Chandler McLeod, Polina V. Zmijewski, Herbert Chen, Jessica M. Fazendin, Brenessa M. Lindeman · 2022 · Journal of Surgical Research
  93. Long term outcome after toxic nodular goitre
    Gabriel Sjölin, Torquil Watt, Kristina Byström, Jan Calissendorff, Per Karkov Cramon, Helena Filipsson Nyström, Bengt Hallengren, Mats Holmberg, Selwan Khamisi, Mikael Lantz et al. · 2022 · Thyroid Research
  94. Cardiovascular Health by Graves’ Disease Management Modality – Surgery Versus Radioactive Iodine Versus Antithyroid Medications: A Network Meta-Analysis
    Peter P. Issa, Mohammad Hosny Hussein, Mahmoud Omar, Ruhul Munshi, Abdallah S. Attia, Yusef J Buti, Mohamed A. Aboueisha, Mohamed Shama, Eman Ali Toraih, Emad H. Kandil · 2022 · Journal of Surgical Research
  95. Secondary Hyperlipidemia and Atherosclerosis in Patients with Thyroid Pathology
    Е. Б. Петрова, Шишко Ольга Николаевна, Т. В. Статкевич, М И Бельская, А. А. Плешко, А.В. Мычкова, Н. П. Митьковская · 2023 · Кардиология в Беларуси
  96. Evaluation of left ventricular myocardial work in patients with hyperthyroidism with different heart rates with noninvasive pressure-strain loop based on two-dimensional speck tracking imaging
    Qian Liu, Lixin Chen, Xiaohua Liu, Guijuan Peng, Xiaofang Zhong, Yuanyuan Sheng, Shuyu Luo, Yuxiang Huang, Jinfeng Xu, Yingying Liu · 2023 · Quantitative Imaging in Medicine and Surgery
  97. Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation
    Pang‐Shuo Huang, Jen‐Fang Cheng, Jien‐Jiun Chen, Yi‐Chih Wang, Juey‐Jen Hwang, Cho‐Kai Wu, Chia‐Ti Tsai · 2023 · The Journal of Clinical Endocrinology & Metabolism
  98. Thyroid volume is the key predictor of hyperthyroidism remission after radioactive iodine therapy in pediatric patients
    М. С. Шеремета, Maria O. Korchagina, А. А. Трухин · 2023 · European Journal of Pediatrics
  99. Association of genetic variations in FoxP3 gene with Graves' disease in a Southwest Chinese Han population
    Guiqin Tan, Guangbing Zheng, Li Jiang · 2023 · Immunity Inflammation and Disease
  100. Association between serum vitamin D level and Graves’ disease: a systematic review and meta-analysis
    Boxian Pang, Leyang Li, Xin Liu · 2024 · Nutrition Journal